At our Woodbridge clinic, we evaluate your symptoms, lifestyle, and wellness goals to determine if B12 therapy aligns with your needs
Safety and metabolism of AOD9604, a novel nutraceutical ingredient for improved metabolic health
Hematologic and myeloproliferative disorders Several blood disorders drive B12 up by increasing the production of its carrier proteins
Patients managing neuropathy, chronic fatigue, or nerve pain often benefit from B12 injections as part of a broader treatment plan
No participants developed antibodies against AOD-9604, and no treatment-related serious adverse events led to study withdrawal

Concentration Calculation 1500mg mixed with 6ml bacteriostatic water provides a concentration of: 250mg/ml Syringe Conversion Guide Quick Reference 1ml = 250mg 0.5ml = 125mg 2ml = 500mg Experimental Research Ranges Lower Experimental Range Research Range 100150mg Frequency: 23 weekly Commonly Investigated In Antioxidant-support research Oxidative-stress regulation pathways Cellular-resilience investigations Example Volumes 100mg = 0.4ml (40 units) 150mg = 0.6ml (60 units) Intermediate Experimental Range Research Range 250mg Frequency: 23 weekly Commonly Investigated In Metabolic-support research Mitochondrial-signaling pathways Pigmentation-related investigations Cellular-maintenance research Example Volume 250mg = 1ml (100 insulin units) Higher-Range Experimental Research Research Range 500mg Frequency: Up to 23 weekly Research Context Considered a higher-range experimental protocol commonly investigated in more intensive antioxidant and oxidative-stress research settings